Development of scalded skin syndrome in an adult patient with acquired epidermolysis bullosa after long-term treatment with methotrexate
- 作者: Olisova O.1, Teplyuk N.1, Ignatiev D.1, Dunaeva E.1
-
隶属关系:
- The First Sechenov Moscow State Medical University (Sechenov University)
- 期: 卷 26, 编号 1 (2023)
- 页面: 41-49
- 栏目: DERMATOLOGY
- URL: https://journals.rcsi.science/1560-9588/article/view/132593
- DOI: https://doi.org/10.17816/dv114845
- ID: 132593
如何引用文章
详细
A clinical case of a patient with epidermolysis bullosa acquisita, which is a rare autoimmune disease ― 0.17–0.26 cases per 1 million population, with the development, most likely against the background of long-term cytostatic therapy with methotrexate, develops staphylococcal scalded skin syndrome is presented.
Staphylococcal scalded skin syndrome is a lesion that appears in 0.09–0.56 cases per 1 million and is predominantly observed in newborns and children under 5 years of age, and cases in adults are usually associated with immunosuppression, human immunodeficiency virus / acquired immunodeficiency syndrome, severe renal failure or malignant neoplasms.
The article presents literature data on the etiology and pathogenesis of the presented diseases, features of differential diagnosis, description of clinical and laboratory criteria, on the basis of which diagnoses are made.
This clinical case is of interest to dermatologists, as it describes the scalded skin syndrome, which is rare in everyday practice, in a patient with acquired epidermolysis bullosa, which, despite ongoing therapy, has a risk of death of up to 65%.
作者简介
Olga Olisova
The First Sechenov Moscow State Medical University (Sechenov University)
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN 代码: 2500-7989
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowNataliа Teplyuk
The First Sechenov Moscow State Medical University (Sechenov University)
Email: teplyukn@gmail.com
ORCID iD: 0000-0002-5800-4800
SPIN 代码: 8013-3256
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, MoscowDmitry Ignatiev
The First Sechenov Moscow State Medical University (Sechenov University)
Email: dmitrywork@list.ru
ORCID iD: 0000-0001-8751-3965
SPIN 代码: 6743-7960
MD
俄罗斯联邦, MoscowEkaterina Dunaeva
The First Sechenov Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: dunaevaer@gmail.com
ORCID iD: 0000-0002-5458-4991
SPIN 代码: 3551-6329
MD
俄罗斯联邦, Moscow参考
- Dermatovenerology. National leadership. Short edition. Ed. by Yu.S. Butov, Yu.K. Skripkin, O.L. Ivanov. Moscow: GEOTAR-Media; 2020. 896 p. (In Russ).
- Goldsmith LA, Katz SI, Gilchrist BA, et al. Fitzpatrick’s dermatology in clinical practice. Ed. by N.N. Potekaev, A.N. Lvov. Transl. from English A.V. Mishchenko, et al. 2nd revised and updated. Moscow: Panfilov Publishing House; 2018. (In Russ).
- Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: Diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28(11):1418–1423. doi: 10.1111/jdv.12541
- Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38(1):149–153. doi: 10.1111/pde.14470
- Zaslavsky DV, Ravodin RA, Tatarskaya OB, et al. Erythroderma: Current issues of diagnosis and treatment. Pediatr. 2014;5(1):97–102. (In Russ). doi: 10.17816/PED5197-102
- Samtsov AV, Belousova IE. Bullous dermatoses. Saint Petersburg: Costa; 2012. 142 p. (In Russ).
- Miyamoto D, Gordilho JO, Santi CG, Porro AM. Epidermolysis bullosa acquisita. An Bras Dermatol. 2022;97(4):409–423. doi: 10.1016/j.abd.2021.09.010
- Koga H, Prost-Squarcioni C, Iwata H, et al. Epidermolysis bullosa acquisita: The 2019 update. Front Med (Lausanne). 2018;5:362. doi: 10.3389/fmed.2018.00362
- Patel S, Cadwell JB, Lambert WC. Comparison of adult vs paediatric staphylococcal scalded skin syndrome inpatients: A retrospective database analysis? Br J Dermatol. 2021;184(4):767–769. doi: 10.1111/BJD.19691
- Ross A, Shoff HW. Staphylococcal scalded skin syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.